News

Bayer, Boehringer lead rapid rise in pharma's social media output

Large pharma companies are posting 530% more tweets a week than in 2013, a study by Ogilvy Healthworld found. The healthcare communications group tracked the social media activity of 14 large pharma companies for one week per month over three months.

WuXi invests $15M in DNAnexus to fuel push into China

DNAnexus has snagged $15 million from WuXi PharmaTech in a Series D round. The deal will see DNAnexus bring its cloud-based genomics platform to China and pair it with WuXi NextCODE's offering.

Lilly, Novartis and Pfizer give trial-patient matching tech to TrialReach

Eli Lilly, Novartis and Pfizer have found a new home for the tech they created to improve ClinicalTrials.gov. The group is giving what it has achieved to date to TrialReach, a tech company developing a patient-focused clinical trial discovery platform.

Edico and Intel set sights on real-time whole genome analysis

Edico Genome has hooked up with Intel in an attempt to shave more minutes off the time it takes to analyze a whole genome. The partnership brings together Edico's NGS analysis hardware and the Intel Xeon microprocessors that reside in many servers used in genomics.

Quest, LabCorp team to build database of cancer genetics

Quest Diagnostics has teamed up with French human health research institute Inserm to pool and share BRCA1 and BRCA2 genetic data. LabCorp has signed up as the first participant in the program, giving it a sizable reach from day one.

AstraZeneca tightens ties to Roche's informatics platform provider

Bina Technologies has unveiled its first publicly known deal with a Big Pharma since it was bought by Roche. The agreement sees AstraZeneca tighten its ties to the genomic data analysis platform provider by becoming the first member of the Bina Alliance Program.

WHO calls for easy linking of bibliographic databases to trial registries

The World Health Organization has updated its position on the disclosure of clinical trial data. Having advocated greater use of registries back in 2005, WHO now wants to see the establishment of a more integrated IT system that includes data from new and old clinical trials.

Sanofi sues drug information startup over side effect info

Sanofi is suing startup Diagnosia over the publication of information about side effects and drug interactions in its physician decision support software.

California starts statewide precision medicine initiative with Atul Butte at the helm

California has become the latest government to set up a precision medicine initiative. And like President Barack Obama's nationwide plan, the success of the state initiative will rest in part on whether it can combine and make sense of different sources of data.

Apple, IBM team up for Watson-fueled assault on health research

Apple just gained a powerful ally in its push to make ResearchKit a core component of the health research toolkit. The Silicon Valley tech giant has tapped IBM for access to Watson, the data-mining and predictive analytics capabilities of which will be applied to health research.

Biopharma puts better use of existing data at top of R&D wish list

A survey by analysts at William Blair has found that biopharma R&D staffers think making better use of existing data is their best hope of improving productivity. Almost half of the 133 respondents said the topic was the biggest remaining opportunity to improve R&D.

PatientsLikeMe adds AstraZeneca to growing list of big-name clients

PatientsLikeMe has struck a 5-year deal to support R&D at AstraZeneca. The agreement tops off a busy and important 12 months for the patient network, in which it has also expanded relationships with Biogen, Roche's Genentech and Swiss biopharma Actelion.

Peking University inks Medidata deal as China inches into eClinical era

Peking University Clinical Research Institute is trying to drag China into the eClinical era by expanding its alliance with Medidata. Under the terms of the revised relationship, the partners will help local drug developers access electronic data capture tools and other eClinical technologies.

BioXcel adds Takeda to its roster of A-list clients

BioXcel has added another big name to its list of clients. Takeda is the latest company to sign up to work with BioXcel, a database-driven drug discovery shop that already boasts relationships with Alexion, Sanofi, Teva and Vertex.

TrialScope offers free ClinicalTrials.gov to EudraCT data conversion service

TrialScope has created a free online tool that converts XML files formatted for uploading to ClinicalTrials.gov to the template used by its European equivalent, EudraCT.

Early user of Venter's DNA synthesizer reports saving time, money

Feedback from an early-access program for Synthetic Genomics' personal DNA workstation has started to emerge. And the initial news is positive, with a researcher at the University of California, San Francisco, reporting that the device is cutting the time and money it takes to synthesize DNA.

Rise of Big Data prompts peer review rethink at Nature Biotechnology

Nature Biotechnology is encouraging authors of computational biology papers to publish their source code on GitHub as part of a company-wide drive to ensure research is reproducible. The policy is designed to counter long-standing concerns about the peer review of computation-heavy research.

Eisai's new research unit taps Genomics for analysis support

Eisai has added to its genomics capabilities. The latest move sees the Japanese drugmaker's nascent Integrated Human Genomics (IHGx) Research Unit team up with Genomics plc, an Oxford University spinout founded in response to the United Kingdom's 100,000 Genomes Project.

Potency-prediction software helps Schrödinger land $120M Sanofi deal

Schrödinger has racked up another tech-validating deal. Having seen the biotech it helped to found rake in $43 million from Pfizer and others last month, the computational drug design veteran has now struck a $120 million discovery deal with Sanofi.

Genentech begins search for bioinformatics chief after Gentleman leaves for 23andMe

The fight for top bioinformatics talent is heating up. With 23andMe poaching Robert Gentleman from Genentech, the Roche-owned Big Biotech now finds itself competing with the likes of Google's Calico in its hunt for a replacement.